quarter. So far, we have seen big news from companies like Google, who beat their marks and also announced a share split, shooting the stock upwards. Friday watched both Wells Fargo and JP Morgan beat their targets, though China’s weak GDP result overshadowed any win in the financial sector. With the coming week packed full of major earnings, we will keep a close eye on three sector SPDRs that would make any arachnophobic cringe [see also 12 High-Yielding Commodities For 2012].
Financial Select Sector SPDR (NYSEARCA:XLF)
XLF is one of the most popular financial funds in the world, with nearly $7 billion in total assets and an average daily trading volume topping 94 million. The fund measures the performance of the biggest financial firms domiciled in the U.S., setting the stage for an important week. The coming trading days will see earnings reports from Citigroup (NYSE:C), Goldman Sachs (NYSE:GS), and Bank of America (NYSE:BAC); all three of which appear in the top ten holdings of this ETF. Together, the three stocks account for approximately 14% of XLF, making this fund an important one to watch as the week unfolds [see also 4 Sector ETFs Up Over 20% YTD].
Consumer Staples Select Sector SPDR (NYSEARCA:XLP)
This ETF seeks to replicate a benchmark that invests in various U.S. firms that are pegged in the consumer staples sector. Two of XLP’s top three holdings will be releasing earnings this week. First, Coca-Cola (NYSE:KO) (12%) will report on Tuesday and is expected to haul in revenues just under $11 billion. Next, Phillip Morris International (NYSE:MO) (11%) will detail its most recent quarter on Thursday; that report is expected to show EPS of 1.19 with revenues of about $7.3 billion. Look for XLP so experience significant volume as the week goes on [see also 10 Equity ETFs That Surged In 2011 (And Might Do The Same In 2012)].
Health Care Select Sector SPDR (NYSEARCA:XLV)
The final SPDR to watch this week focuses its efforts on the U.S. health care sector, one that has been at the forefront of the media as a controversial health care bill has just made its way through the Supreme Court. Earnings from Johnson & Johnson (NYSE:JNJ) (12.5%) and Abbott (NYSE:ABT) (5.6%) will keep XLV active on the week. JNJ’s estimates peg an EPS of 1.35 and revenues of $16 billion; note that the company has not missed their marks in over a year. Abbott, another company known for sound earnings management, is expected to report revenues around $9.4 billion and may shed more light on the company split that was announced several weeks ago.
Written By Jared Cummans From ETF Database Disclosure: No Positions.
ETF Database is committed to giving our audience, consisting of both active traders and buy-and-hold investors, information that, to our knowledge, is truthful and non-biased. [For more ETF insights, sign up for our free ETF newsletter or try a free seven day trial of ETFdb Pro.]